AstraZeneca PLC, Bristol-Myers Squibb Company Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc.

Bristol-Myers Squibb Co. (NASDAQ:BMY) and AstraZeneca plc (NYSE:AZN) have teamed up to execute a uniquely structured takeover of diabetes firm Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) for a total val…
Read the full story: BioSpace.com Featured News